Amy Palin on Muck Rack

Amy Palin

As seen in: Nature, Cell Press

Get in touch with Amy

Contact Amy, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Interleukin-17-Producing γδ T Cells Originate from SOX13 + Progenitors that Are Independent of γδTCR Signaling

|
By Nicholas A. Spidale, Katelyn Sylvia, Kavitha Narayan, Bing Miu, Michela Frascoli, Heather J. Melichar, WU Zhihao, Jan Kisielow, Amy Palin, Thomas Serwold, Paul Love, Michihiro Kobayashi, Momoko Yoshimoto, Nitya Jain, Joonsoo Kang
| Cell Press Verified
Main text (Immunity , 857–872.e1–e5; November 20, 2018) In the originally published version of this article, the Declaration of Interests statement was incomplete. Author Kavitha Scranton (née Narayan) is currently employed by Elsevier as a scientific editor at . Her contributions to this study were performed prior to joining Elsevier, during her graduate and postdoctoral training at UMass Chan Medical School.
Open in Who Shared Issue with article?

Author Correction: Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV—workshop report - npj Vaccines

|
By Milton Maciel Jr, Rama R. Amara, Shane Crotty, Amy Palin
| Nature Verified
Correction to: npj Vaccines https://doi.org/10.1038/s41541-024-00818-y, published online 21 February 2024 In the original version of this Meeting Report, the incorrect statement “Out of nine HIV-1 vaccine efficacy trials completed so far, all but one demonstrated correlates of protection4” was inserted by mistake. The correct statement should have been “Out of nine HIV-1 vaccine efficacy trials completed so far, only one demonstrated correlates of protection4”.
Open in Who Shared View Duplicates (6) Issue with article?

Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV—workshop report - npj Vaccines

|
By Milton Maciel Jr, Rama R. Amara, Shane Crotty, Amy Palin
| Nature Verified
The US National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institute of Health (NIH), convened a virtual workshop on August 8-9th, 2023 to explore potential synergies between HIV vaccine approaches that are designed to induce cellular or humoral immune responses. The goal of this workshop was to review data on leading vaccine candidates and to discuss the best strategies for combining these approaches to optimize immunity against HIV.
Open in Who Shared Issue with article?
See all 5 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified